모바일 헬스 앱 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 플랫폼별, 지역별, 부문별 예측(2025-2030년)

mHealth Apps Market Growth & Trends:

The global mHealth apps market size is estimated to reach USD 86.37 billion by 2030, registering to grow at a CAGR of 14.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growing reach of the internet & smartphones, coupled with the increasing adoption of mobile health applications among medical practitioners & patients, contributes significantly to the market growth. An increasing awareness of lifestyle improvement & personal health and wellness drives the market. In addition, the rapid growth of remote healthcare services fuels mobile health application adoption. Moreover, physicians' increasing use of patient-centric healthcare applications to enhance patient engagement and treatment outcomes is expected to boost their adoption further.

Smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Mobile applications for smartphones have made life easy by making it convenient to perform daily activities. Some companies are developing chatbot services for one-time consultations or basic medical inquiries. For instance, WeChat in China offers Chatbot services for basic medical inquiries in addition to other mobile health solutions, such as booking an appointment, accessing medical records, and paying medical bills. Thus, rising importance of mobile phones and mHealth for improving health outcomes & patient care will drive market growth. The rise of mHealth technologies and patient centric healthcare apps, adoption of various strategies by players, and technological advancements have resulted in increased funding for digital health.

In addition, physicians with experience in company operations or investments invest in digital health startups. This is expected to have a positive impact on the market growth. For instance, in October 2023, in California, Cedar-Sinai launched a new mobile application that enables patients to access their experts for sick, chronic, and preventive care conveniently and promptly. This virtual healthcare service has been expanded to cater to the needs of the patient base. Furthermore, the surge in initiatives and investments supporting mHealth & digital health such as patient centric healthcare apps involves significant backing from venture capitalists, private equity firms, and healthcare organizations.

The global health-tech investment landscape witnessed a substantial boost in 2021, reaching over USD 44 billion, which represents a twofold increase compared to the previous year. This influx of capital underscores the growing importance of technological innovation in healthcare. Notably, large tech-enabled platform companies are emerging as key players, offering the potential to enhance hospital and health system efficiencies, rapidly scale operations, and modernize existing systems & delivery models. In addition, these platforms are positioned to play a pivotal role in addressing health equity concerns through a comprehensive and inclusive approach to healthcare delivery.

mHealth Apps Market Report Highlights:

• The medical segment accounted for the largest revenue share of 73.0% in 2024.
• The iOS platform segment accounted for the largest revenue share of 39.7% in 2024.
• The Android segment is anticipated to grow at the fastest CAGR over the forecast period.
• North America mHealth apps market dominated the global industry with a revenue share of 37.7% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Platform outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. mHealth Apps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Parent Market Outlook
• 3.3. Ancillary Market Outlook
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. High penetration of smartphones
    • 3.4.1.2. Favorable government initiatives
    • 3.4.1.3. Growing adoption of mobile health applications
    • 3.4.1.4. Increase in investments supporting mHealth & digital health
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Concerns related to data security
    • 3.4.2.2. Barriers to scalability and adoption
• 3.5. Case Study Analysis
  • 3.5.1. Case Study 1: Kilkari: a mobile health service for mothers in India
  • 3.5.2. Case Study 2: Momconnect: empowering mothers in south africa
  • 3.5.3. Case Study 3: Integrating mobile technology with existing healthcare infrastructure to enhance healthcare accessibility
  • 3.5.4. Case Study 4: Jhpiego's mwater project
  • 3.5.5. Case Study 5: A web platform for clinician & patient interaction
  • 3.5.6. Case Study 6: European firms have created digital technologies that can scale up to offer solutions for clinical settings, remote care, health insurance, and patient-centered eHealth services
  • 3.5.7. Case Study 7: SMS to promote medicines adherence in South Africa
  • 3.5.8. Case Study 8: MPOWER: Improving HIV medication adherence in Rwanda
  • 3.5.9. Case Study 9: Omada Health: Digital tools for weight loss and diabetes prevention
• 3.6. mHealth Apps: Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis
• 3.7. Emerging Technological Trends in the mHealth App Market
• 3.8. Technology Landscape in the mHealth App Market
  • 3.8.1. Technological Advancements Driving mHealth Innovation
  • 3.8.2. mHealth Software Platforms and Mobile Applications
  • 3.8.3. Use of Data Analytics, Machine Learning, and AI in mHealth
  • 3.8.4. Integration of Wearable Devices and IoT with mHealth Apps
  • 3.8.5. Mobile Connectivity and Telecommunication Infrastructure Enabling mHealth Delivery
• 3.9. Key Use Cases in Chronic Disease Management via mHealth Apps
• 3.10. Regulatory and Reimbursement Scenario, by Country
• 3.11. Value Chain Analysis
  • 3.11.1. Overview of the mHealth Value Chain
  • 3.11.2. Key Stakeholders: Developers, Providers, Payers, and Users
  • 3.11.3. Technology Providers and Platform Enablers in mHealth
  • 3.11.4. Service Delivery, Interoperability, and Integration with EHRs
  • 3.11.5. App Distribution Channels and Supply Chain Management
  • 3.11.6. Revenue Models and Monetization Strategies (e.g., freemium, subscription, DTx reimbursement)
• 3.12. Market Funding/Investment Scenario
  • 3.12.1. Venture capital (VC) deal activity
  • 3.12.2. Top 10 digital health VC deals in 2024
  • 3.12.3. Annual equity funding & deals
  • 3.12.4. Quarterly equity funding & deals
  • 3.12.5. Quarter funding & deals by global region
  • 3.12.6. Percent of quarterly deals by global region
  • 3.12.7. Percent of quarterly deals by investor group
  • 3.12.8. Annual average & median deal size
  • 3.12.9. Annual median deal size by global region
  • 3.12.10. Annual median deal size by investor group
  • 3.12.11. Annual mega-round funding & deals
  • 3.12.12. Quarterly funding & deals from mega-rounds (deals worth USD 100 million+)
  • 3.12.13. Quarter mega-round funding & deals by global region
  • 3.12.14. Quarterly mega-round deals by global region
  • 3.12.15. Quarterly mega-rounds as a percentage of funding
  • 3.12.16. Quarter top equity deals
  • 3.12.17. Annual percentage of deals by deal stage
  • 3.12.18. Quarter regional deal shares by deal stage
  • 3.12.19. Annual median funding by deal stage
  • 3.12.20. Quarter top seed/angel deals
  • 3.12.21. Quarter top series A deals
  • 3.12.22. Quarter top series B deals
  • 3.12.23. Quarter top series C deals
  • 3.12.24. Quarter top series D deals
  • 3.12.25. Quarter top series E+ deals
• 3.13. Unicorn Funding Trends in Digital Health
  • 3.13.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
  • 3.13.2. Quarter new & total unicorns by global region
  • 3.13.3. Quarterly new unicorns by global region
  • 3.13.4. Quarter top unicorns by valuation
• 3.14. Exit Trends in Digital Health Market
  • 3.14.1. Annual exits
  • 3.14.2. Quarterly exits
  • 3.14.3. Percent of quarterly exits by global region
  • 3.14.4. Quarter top M&A exits
  • 3.14.5. Quarter top IPOs
• 3.15. Key Investors Analysis in the Digital Health Landscape
  • 3.15.1. Quarter top investors by company count
  • 3.15.2. Quarter top VCs by company count
  • 3.15.3. Quarter top corporate VCs (CVCs) by company count
• 3.16. Key Investment Geographic Trends in Digital Health Market
  • 3.16.1. U.S. Trends
    • 3.16.1.1. Annual funding & deals
    • 3.16.1.2. Quarterly funding & deals
    • 3.16.1.3. Annual percentage of deals by deal stage
    • 3.16.1.4. Quarter top equity deals
    • 3.16.1.5. Annual exits
    • 3.16.1.6. Quarterly exists
    • 3.16.1.7. Quarter top investors by company count
  • 3.16.2. Asia Trends
    • 3.16.2.1. Annual funding & deals
    • 3.16.2.2. Quarterly funding & deals
    • 3.16.2.3. Annual percentage of deals by deal stage
    • 3.16.2.4. Quarter top equity deals
    • 3.16.2.5. Annual exits
    • 3.16.2.6. Quarterly exists
    • 3.16.2.7. Quarter top investors by company count
  • 3.16.3. China
  • 3.16.4. Japan
  • 3.16.5. Europe Trends
    • 3.16.5.1. Annual funding & deals
    • 3.16.5.2. Quarterly funding & deals
    • 3.16.5.3. Annual percentage of deals by deal stage
    • 3.16.5.4. Quarter top equity deals
    • 3.16.5.5. Annual exits
    • 3.16.5.6. Quarterly exists
    • 3.16.5.7. Quarter top investors by company count
  • 3.16.6. UK

Chapter 4. mHealth Apps Market Segment Analysis, By Type, 2018-2030 (USD Million)

• 4.1. Definitions and Scope
• 4.2. Type Segment Dashboard
• 4.3. Global mHealth Apps Market, by Service Type, 2018 to 2030
• 4.4. Medical Apps
  • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Women's Health Apps
    • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.2. Fitness & Nutrition Apps
      • 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.3. Menstrual Health
      • 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.4. Pregnancy Tracking & Postpartum Care Apps
      • 4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.5. Disease Management Apps
      • 4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.6. Menopause Apps
      • 4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.7. Others
      • 4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Chronic Disease Management Apps
    • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.2. Obesity Management Apps
      • 4.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.3. Mental Health Management Apps
      • 4.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.4. Diabetes Management Apps
      • 4.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.5. Blood Pressure and ECG Monitoring Apps
      • 4.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.6. Cancer Management Apps
      • 4.4.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.7. Other Chronic Disease Management Apps
      • 4.4.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Personal Health Record Apps
    • 4.4.4.1. Market estimates and forecast 2018 to 2030, (USD Million)
  • 4.4.5. Medication Management Apps
    • 4.4.5.1. Market estimates and forecast 2018 to 2030, (USD Million)
  • 4.4.6. Diagnostic Apps
    • 4.4.6.1. Market estimates and forecast 2018 to 2030, (USD Million)
  • 4.4.7. Remote Monitoring Apps
    • 4.4.7.1. Market estimates and forecast 2018 to 2030, (USD Million)
  • 4.4.8. Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)
    • 4.4.8.1. Market estimates and forecast 2018 to 2030, (USD Million)
• 4.5. Fitness Apps
  • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. mHealth Apps Market Segment Analysis, By Platform, 2018-2030 (USD Million)

• 5.1. Definitions and Scope
• 5.2. Platform Segment Dashboard
• 5.3. Global mHealth Apps Market by Platform Outlook, 2018 to 2030
• 5.4. Android
  • 5.4.1. Market estimates and forecast 2018 to 2030, (USD million)
• 5.5. iOS
  • 5.5.1. Market estimates and forecast 2018 to 2030, (USD Million)
• 5.6. Others
  • 5.6.1. Market estimates and forecast 2018 to 2030, (USD Million)

Chapter 6. mHealth Apps Market: Segment Analysis, By Region, 2018- 2030 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. mHealth Apps Market Share by Region, 2024 & 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Apple Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Google Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. AirStrip Technologies, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Samsung Electronics Co. Ltd.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Veradigm LLC (Allscripts Healthcare Solutions)
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Qualcomm Technologies, Inc.
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. AT&T
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Orange
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Teladoc Health, Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. AstraZeneca
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Abbott
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Sanofi
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Johnson & Johnson Services, Inc.
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Novartis AG
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. Pfizer Inc.
    • 7.4.15.1. Company overview
    • 7.4.15.2. Financial performance
    • 7.4.15.3. Product benchmarking
    • 7.4.15.4. Strategic initiatives